Summary

After facing a 15-year delay in receiving a proper multiple sclerosis diagnosis due to gender and racial bias, Lorrayne Anthony has managed her MS for four decades. This profile explores the daily realities of living with an invisible disability, Canadian MS prevalence statistics, and promising new research from the University of Manitoba on a brain-repairing protein called neuregulin-1.

Lorrayne Anthony was 20 years old when the strange symptoms started. Numbness that spread from her shoulders down. A crushing tightness around her chest that made it hard to breathe. Vision that vanished from one eye while she was driving on her honeymoon.

She spent the next 15 years being told it was nothing.

“I was showing all the symptoms of MS,” she says. “It immediately got ticked off.” The reason, as one doctor explained it in the early 1980s: multiple sclerosis was a white person’s disease. Lorrayne, who is of Indian descent with brown skin, didn’t fit the picture.

When she couldn’t feel anything from her shoulders down, a doctor told her it was “something that can happen to women.” When she lost vision in her left eye, she was told her eyes were “pretty good for a woman of your age.” The chest tightness, now recognized as the “MS hug,” she chalked up to needing a different bra size. She was 22.

“If a man couldn’t feel anything from the shoulders down, you would at least have a name for it,” she says.

The diagnosis finally came at 35, after her doctor dismissed the idea of “postpartum numbness” and sent her for testing. Fifteen years of symptoms, and no one had put the pieces together.

MS in Canada

Lorrayne’s story is far from rare in this country. Canada has one of the highest rates of multiple sclerosis in the world, with over 90,000 Canadians living with MS, about 1 in every 400 people, and about 75% of them women, according to MS Canada. Among Canadians aged 20 and older, roughly 290 out of every 100,000 live with the disease.

The treatment she refused

By the time she was diagnosed, Lorrayne had two young children. The standard treatment at the time was a daily injection, and the prospect terrified her. “I do not like injections,” she says plainly. “I knew that was not for me.”

But it wasn’t just the needle. The drugs worked by suppressing the immune system, and with small children bringing home every germ in circulation, she did the math. “I just thought, well, I will have a cold every day of my life.”

So she said no. Her doctors, she says, “kind of threw their hands up.” They don’t even raise the subject anymore.

Forty years on, she has no regrets. She’s had a family, a successful career, and a full life. “I actually like my immune system being intact,” she says. She’s careful to add that her experience is anecdotal, not evidence. But for her, the decision held.

What MS actually feels like day to day

Lorrayne is able-bodied. She walks, works out, cooks elaborate meals. And that, she says, is its own problem.

“On the one hand, people think you can’t do stuff. On the other hand, people think you can do stuff.”

At her gym, a well-meaning stranger once walked into the dimly lit stretch room and flipped on all the lights. “That just sent me into such a dizzy spell,” she says. “It was about two days.”

These aren’t full relapses. She can still walk. But the dizziness, the hypersensitivity to light and sound, can linger for days. She calls them mini-relapses, and they arrive without warning.

“It’s not a one size fits all,” she says. “It differs person by person. It differs for me day to day. There are some days I can’t get out of bed, and then there are some days I can go to a dance party.”

Dancing is one of the things she’s had to mourn. She trained seriously as a young woman, then chose biology over a dance career in her third year of university. Now her body won’t move the way her mind wants it to. “You kind of have to mourn the things you can’t do,” she says.

A protein that could change everything

This is where Lorrayne’s story meets a potentially breakthrough piece of Canadian research.

A team at the University of Manitoba, led by Dr. Soheila Karimi, discovered that a protein called neuregulin-1 is depleted in brains affected by chronic MS. When they restored it in mice, brain and spinal cord damage decreased, and mobility and cognition problems reversed. It even outperformed an approved MS treatment in mice, at a much lower dose.

The work is still at the animal stage. The next step is developing a clinical-grade peptide, then human trials. But the concept is radically different from existing treatments: instead of suppressing the immune attack, it aims to restore the brain’s ability to repair itself.

When told about the research, Lorrayne didn’t hesitate. “That sounds amazing,” she says. “If it can go back and repair, that’s amazing.”

What caught her attention, with her biology background, is the mechanism. Current disease-modifying drugs work by dampening the immune system. This would do the opposite: replenish something the MS brain has lost. “I’m not opposed to taking a drug,” she says. “I guess I was opposed to taking ones that would make the symptoms less by just wiping out my immune system.”

She plans to read up on the research herself. “This is very fascinating,” she says. And if a human trial ever came around: she’d consider it.

The search continues

Lorrayne is under no illusions about timelines. Mouse research is years from helping anyone. But after four decades of managing a disease that once went undiagnosed because of the colour of her skin, she’s still watching the science closely.

“I’m glad we’re still doing research, for sure,” she says. Her message to other Canadians living with MS is simpler: “It differs day to day. And you don’t always know what you’re gonna get.”

After 40 years, she’s still adapting. Still working out. Still cooking, though she’s learned to buy pre-cut vegetables. And still, on the good days, going to the dance party.

Subscribe to The Health Insider newsletter where you’ll find many more insights, delivered straight to your inbox.

~ Read more from The Health Insider ~


The information provided on TheHealthInsider.ca is for educational purposes only and does not substitute for professional medical advice. TheHealthInsider.ca advises consulting a medical professional or healthcare provider when seeking medical advice, diagnoses, or treatment. To read about our editorial review process click here.

0 Shares:
You May Also Like